

Most Read This Week
- FDA Approves Wezlana for Multiple Inflammatory Diseases
- Risk of Melanoma and Nonmelanoma Skin Cancer in Patients With Vitiligo
- Role of Physical Touch During Patient Examination in Dermatology
- Cardiovascular and Venous Thromboembolic Risk Associated With JAK Inhibitor Use in Patients With Immune-Mediated Inflammatory Skin Diseases
- Impact of Hormonal Contraception Type on Hidradenitis Suppurativa Disease Control
Recently Updated
- AI Accurate in Diagnosing Suspicious Skin Lesions
- Interpreter Resources for Patients Who Speak Spanish at Dermatology Residency Program Clinics
- Management of Adults With a Drug Reaction With Eosinophilia and Systemic Symptoms
- Risk and Characteristics of Melanoma and Melanocytic Nevi in Patients With Neurofibromatosis Type 1
- Value of Mohs Micrographic Surgery for Treating Melanoma and Melanoma in Situ on the Trunk and Extremities